Buy Versartis Stock | VSAR Stock Price & Latest News | Public
VSAR

Versartis

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About VSAR

    Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion prote...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$100,16M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.62
    1 Year Low$3.34
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app